Katherine A. Stueland — Chief Commercial Officer at Invitae Corporation

Ms. Katherine A. Stueland has been Chief Commercial Officer at Invitae Corporation since October 2016. Ms. Stueland served as Head of Commercial, Communications and Investor Relations at Invitae Corporation since October 15, 2016 until October 2016. Ms. Stueland served as an Associate of WeissComm Partners, Inc. Ms. Stueland served as Vice President of Corporate Communications and Investor Relations at Dendreon Corp. Ms. Stueland joined WeissComm from TAP Pharmaceutical Products Inc., where she served as the Head of Public Affairs and was responsible for providing strategic counsel to the executive leadership team and managing product and marketing public relations for Prevacid for acid reflux and Lupron Depot for prostate cancer and other indications. She has particular expertise in crisis management, corporate reputation management and executive communications. Ms. Stueland played an integral role in supporting the launch and rapid growth of Prescott Medical Communications, a medical education and publications planning agency based in Chicago. She began her career at BSMG Medical and Healthcare Communications (now Weber Shandwick), supporting communications programs for a variety of healthcare clients. She also led the public affairs team at Takeda Abbott Pharmaceuticals (TAP) and worked with a variety of biotechnology and pharmaceutical companies on their communications strategies. Ms. Stueland serves as Member of Strategy Team at InVitae Corporation. At Invitae, Ms. Stueland is responsible for communications, public relations, investor relations, advocacy and thought leader development. Ms. Stueland graduated from Miami University in Ohio.